These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 35513611)
1. A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models. Lang M; Grünewald A; Pramstaller PP; Hicks AA; Pichler I Cell Mol Life Sci; 2022 May; 79(5):283. PubMed ID: 35513611 [TBL] [Abstract][Full Text] [Related]
2. The cybrid model of sporadic Parkinson's disease. Trimmer PA; Bennett JP Exp Neurol; 2009 Aug; 218(2):320-5. PubMed ID: 19328199 [TBL] [Abstract][Full Text] [Related]
3. Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence. Swerdlow RH Antioxid Redox Signal; 2012 May; 16(9):950-64. PubMed ID: 21338319 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial quality, dynamics and functional capacity in Parkinson's disease cybrid cell lines selected for Lewy body expression. Cronin-Furman EN; Borland MK; Bergquist KE; Bennett JP; Trimmer PA Mol Neurodegener; 2013 Jan; 8():6. PubMed ID: 23351342 [TBL] [Abstract][Full Text] [Related]
5. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects. Müller-Nedebock AC; Brennan RR; Venter M; Pienaar IS; van der Westhuizen FH; Elson JL; Ross OA; Bardien S Neurochem Int; 2019 Oct; 129():104495. PubMed ID: 31233840 [TBL] [Abstract][Full Text] [Related]
6. Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk. Müller-Nedebock AC; van der Westhuizen FH; Kõks S; Bardien S Mov Disord; 2021 Apr; 36(4):815-831. PubMed ID: 33513296 [TBL] [Abstract][Full Text] [Related]
7. Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease. Ghosh SS; Swerdlow RH; Miller SW; Sheeman B; Parker WD; Davis RE Ann N Y Acad Sci; 1999; 893():176-91. PubMed ID: 10672237 [TBL] [Abstract][Full Text] [Related]
8. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease. Pinto M; Nissanka N; Moraes CT J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404 [No Abstract] [Full Text] [Related]
9. Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines. Trimmer PA; Swerdlow RH; Parks JK; Keeney P; Bennett JP; Miller SW; Davis RE; Parker WD Exp Neurol; 2000 Mar; 162(1):37-50. PubMed ID: 10716887 [TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of cybrids expressing mitochondrial DNA from Contursi kindred Parkinson's subjects. Swerdlow RH; Parks JK; Cassarino DS; Binder DR; Bennett JP; Di Iorio G; Golbe LI; Parker WD Exp Neurol; 2001 Jun; 169(2):479-85. PubMed ID: 11358461 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Esteves AR; Domingues AF; Ferreira IL; Januário C; Swerdlow RH; Oliveira CR; Cardoso SM Mitochondrion; 2008 Jun; 8(3):219-28. PubMed ID: 18495557 [TBL] [Abstract][Full Text] [Related]
13. Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration-a Need for Therapeutic Approach in Parkinson's Disease (PD). Venkatesan D; Iyer M; Narayanasamy A; Gopalakrishnan AV; Vellingiri B Mol Neurobiol; 2023 Dec; 60(12):6992-7008. PubMed ID: 37523043 [TBL] [Abstract][Full Text] [Related]
14. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family. Swerdlow RH; Parks JK; Davis JN; Cassarino DS; Trimmer PA; Currie LJ; Dougherty J; Bridges WS; Bennett JP; Wooten GF; Parker WD Ann Neurol; 1998 Dec; 44(6):873-81. PubMed ID: 9851431 [TBL] [Abstract][Full Text] [Related]
15. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579 [TBL] [Abstract][Full Text] [Related]
16. Current perspective of mitochondrial biology in Parkinson's disease. Ammal Kaidery N; Thomas B Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604 [TBL] [Abstract][Full Text] [Related]
17. Damage in Mitochondrial DNA Associated with Parkinson's Disease. Martín-Jiménez R; Lurette O; Hebert-Chatelain E DNA Cell Biol; 2020 Aug; 39(8):1421-1430. PubMed ID: 32397749 [TBL] [Abstract][Full Text] [Related]
18. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Perfeito R; Cunha-Oliveira T; Rego AC Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292 [TBL] [Abstract][Full Text] [Related]
19. Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson's subject mitochondrial transfer. Esteves AR; Lu J; Rodova M; Onyango I; Lezi E; Dubinsky R; Lyons KE; Pahwa R; Burns JM; Cardoso SM; Swerdlow RH J Neurochem; 2010 May; 113(3):674-82. PubMed ID: 20132468 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]